Premium
Asparagus P R cannot compete with first‐line diuretics in lowering the blood pressure in treatment‐requiring antihypertensives
Author(s) -
Chrubasik Sigrun,
deceased Conrad Droste,
Black Andy
Publication year - 2009
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.2787
Subject(s) - asparagus , medicine , diuretic , adverse effect , blood pressure , liliaceae , pharmacology , botany , biology
A six week clinical surveillance of 163 patients receiving maximally tolerable doses of Asparagus P ® , a proprietary mixture pulversied dried asparagus root and parsley leaf, has not indicated any clinically useful antihypertensive effect. The profile of adverse events (with 7 patients leaving the surveillance early because of renally related complaints) contraindicates its use in hypertension or to promote flushing of the efferent tract in rental inflammatory conditions or urolithiasis. Copyright © 2009 John Wiley & Sons, Ltd.